Clinical Trial Update: Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing etrasimod to placebo as induction therapy in moderately to severely active ulcerative colitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Etrasimod (etrasimod)

Snippet

Sponsor: Arena Pharmaceuticals | Conditions: Ulcerative Colitis | Phase 3 | Status: COMPLETED | Results posted: 2022-12-21